Posted September 17, 2019
Meric-Bernstam F, Akcakanat A, Chen H, Do KA, Sangai T, Adkins F, Gonzalez-Angulo AM, Rahsid A, Crosby K, Dong M, Phan AT, Chang DZ, Wolff RA, Gupta S, Mills GB, Yao J. PIK3CA/PTEN mutations and AKT activation as markers of sensitivity to allosteric mTOR inhibitors. Clin Cancer Res. 2012 Mar 15;18(6):1777-89.